已收录 268921 条政策
 政策提纲
  • 暂无提纲
Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
[摘要] BackgroundWe report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment.Case presentationA 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization.ConclusionsPostoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results.
[发布日期] 2017-12-06 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Vancomycin;Hemorrhagic occlusive retinal vasculitis;Cataract surgery;Anti-VEGF [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文